Last $346.00 USD
Change Today -14.67 / -4.07%
Volume 1.1M
BIIB On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 11:20 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas Edward Williams Ph.D.

Executive Vice President of Research & Development, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 72 board members in 6 different organizations across 14 different industries.

See Board Relationships
56$5,246,398
As of Fiscal Year 2013

Background*

Dr. Douglas Edward Williams, also known as Doug, Ph.D. has been an Executive Vice President of Research & Development at Biogen Idec Inc. since January 5, 2011. Dr. Williams served as Secretary of Fred Hutchinson Cancer Research Center. Dr. Williams served as the Chief Executive Officer of Zymogenetics Inc. from January 2, 2009 to November 2010. Dr. Williams served as the President of Zymogenetics Inc. from July 2, 2007 to January 2009. Dr. Williams joined ZymoGenetics ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 781-464-2000
Fax: --

Board Members Memberships*

Former Chairman of The Board
Former Trustee
1995-2005
Former Director and Director of Strategic Development and Health
1996-N/A
Former Chief Technology Officer, Executive Vice President and Director
2001-2005
Former Director
2004-2011
Former Director and Member of Compensation Committee
2004-2009
Former Independent Director, Chairman of Compensation Committee and Member of Corporate Governance & Nominating Committee
2006-Present
Director
2009-2013
Former Director and Member of Audit Committee
2009-N/A
Former Chief Executive Officer
2012-Present
Director
2014-Present
Director

Education*

BS
University of Massachusetts Lowell
PhD
State University of New York at Buffalo Roswell Park Memorial Institute Division

Other Affiliations*

Annual Compensation*

Salary$766,831
Total Annual Compensation$766,831

Stock Options*

Restricted Stock Awards$3,575,514
All Other Compensation$184,017

Total Compensation*

Total Annual Cash Compensation$1,670,884
Total Short Term Compensation$766,831
Other Long Term Compensation$3,759,531
Total Calculated Compensation$5,246,398
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $345.89 USD -14.78

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.